Display Settings:

Format

Send to:

Choose Destination
    Acta Psychiatr Scand. 1984 Mar;69(3):259-61.

    Zimeldine treatment of obsessive-compulsive disorder. Biological and neuropsychological aspects.

    Abstract

    Six patients with Obsessive-Compulsive Disorder (DSM III) were treated in an open uncontrolled trial with Zimeldine, for 8 weeks. All six patients had cognitive deficits before treatment. Five patients improved on the clinical symptoms. Four of these showed pronounced amelioration of their cognitive deficits.

    PMID:
    6231806
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk